120 related articles for article (PubMed ID: 17349798)
1. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
Tentori L; Graziani G
Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
[TBL] [Abstract][Full Text] [Related]
2. Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.
Anderson LJ; Tamayose JM; Garcia JM
Mol Cell Endocrinol; 2018 Mar; 464():65-74. PubMed ID: 28606865
[TBL] [Abstract][Full Text] [Related]
3. Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).
Krasanakis T; Nikolouzakis TK; Sgantzos M; Mariolis-Sapsakos T; Souglakos J; Spandidos DA; Tsitsimpikou C; Tsatsakis A; Tsiaoussis J
Oncol Rep; 2019 Dec; 42(6):2228-2244. PubMed ID: 31578582
[TBL] [Abstract][Full Text] [Related]
4. Studies of Human Osteoblast-like Cells - Effects of Growth Hormone and Steroids.
Swolin-Eide D
EJIFCC; 2002 Jun; 13(4):119-124. PubMed ID: 30386193
[No Abstract] [Full Text] [Related]
5. Unmodified performance in runners following anabolic steroid administration.
Ballarin E; Guglielmini C; Martinelli S; Casoni I; Borsetto C; Ziglio PG; Conconi F
Int J Sports Med; 1986 Dec; 7(6):302-6. PubMed ID: 3100466
[TBL] [Abstract][Full Text] [Related]
6. [Growth hormone and IGF-1 as doping agents in competitive sport].
Jóźków P; Medraś M
Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
[TBL] [Abstract][Full Text] [Related]
7. Use of hormones in doping and cancer risk.
De Santi M; Baldelli G; Brandi G; ;
Ann Ig; 2019; 31(6):590-594. PubMed ID: 31616903
[TBL] [Abstract][Full Text] [Related]
8. Anabolic steroids and growth hormone.
Haupt HA
Am J Sports Med; 1993; 21(3):468-74. PubMed ID: 8346765
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone, IGF-I and insulin and their abuse in sport.
Holt RI; Sönksen PH
Br J Pharmacol; 2008 Jun; 154(3):542-56. PubMed ID: 18376417
[TBL] [Abstract][Full Text] [Related]
10. Doping and sports endocrinology: growth hormone, IGF-1, insulin, and erythropoietin.
García-Arnés JA; García-Casares N
Rev Clin Esp (Barc); 2023 Mar; 223(3):181-187. PubMed ID: 36736729
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target.
Liu G; Zhu M; Zhang M; Pan F
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831629
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of anabolic steroids in improving outcomes for post-operative hip fracture patients: A randomized controlled trial.
Yam MGJ; Paramasivam Meenakshi Sundaram P; Ho SWL; Kwek EBK
J Clin Orthop Trauma; 2022 Jul; 30():101913. PubMed ID: 35711820
[TBL] [Abstract][Full Text] [Related]
13. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review.
Albano GD; Amico F; Cocimano G; Liberto A; Maglietta F; Esposito M; Rosi GL; Di Nunno N; Salerno M; Montana A
Healthcare (Basel); 2021 Jan; 9(1):. PubMed ID: 33477800
[TBL] [Abstract][Full Text] [Related]
14. Nandrolone Decanoate: Use, Abuse and Side Effects.
Patanè FG; Liberto A; Maria Maglitto AN; Malandrino P; Esposito M; Amico F; Cocimano G; Rosi GL; Condorelli D; Nunno ND; Montana A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33187340
[No Abstract] [Full Text] [Related]
15. Can Plasma Rich in Growth Factors Be Safe for Parental Use? A Safety Study in the Canine Model.
Damiá E; Chicharro D; Rubio M; Carrillo JM; Sopena J; Cuervo B; López S; Vilar JM
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208586
[TBL] [Abstract][Full Text] [Related]
16. Serum reference value of two potential doping candidates-myostatin and insulin-like growth factor-I in the healthy young male.
Han DS; Huang CH; Chen SY; Yang WS
J Int Soc Sports Nutr; 2017; 14():2. PubMed ID: 28077934
[TBL] [Abstract][Full Text] [Related]
17. Gene doping in sport - perspectives and risks.
Brzeziańska E; Domańska D; Jegier A
Biol Sport; 2014 Dec; 31(4):251-9. PubMed ID: 25435666
[TBL] [Abstract][Full Text] [Related]
18. Currently neglected, physical examination maintains its clinical relevance.
Rossi RE; Girelli CM; Bernasconi G; Conte D
Intern Emerg Med; 2014 Dec; 9(8):871-4. PubMed ID: 25253634
[No Abstract] [Full Text] [Related]
19. Influence of Intramuscular Application of Autologous Conditioned Plasma on Systemic Circulating IGF-1.
Schippinger G; Oettl K; Fankhauser F; Spirk S; Domej W; Hofmann P
J Sports Sci Med; 2011; 10(3):439-44. PubMed ID: 24150615
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
